May 1, 2025
| Today’s news and insights for medtech leaders
The full-year tariff impact of 85 cents per share would have more than doubled without mitigation actions underway, executives said on the earnings call.
|
The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device with Senseonics’ Eversense 365 CGM.
|
In another lawsuit against the HHS over the grant cuts, municipalities in Texas, Tennessee, Ohio and Missouri, as well as a labor union, argue eliminating the funding would weaken their ability to respond to infectious disease outbreaks.
|
From 2017 to 2023, variables in Phase I studies increased by 35%. Learn how to nimbly approach the increasingly complex task of running a clinical trial in
|
Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm Society’s annual meeting.
|
From the Archives
New pulsed field ablation systems from Boston Scientific and Medtronic are already reshaping the cardiac ablation market, but upcoming devices could spur even greater adoption.
|
UPDATED
In a letter to the FTC, three Democratic senators called for privacy standards for brain computer interface technology.
|
|
Product liability coverage is an essential tool for safeguarding your business’s balance sheet and reputation. Explore how to consider risk management partners for your life sciences business in this playbook.
|
|
From Our Library
Playbook
Custom content for Infor
|
Playbook
Custom content for Medrio
|
View all resources
What We're Reading
| 
